Diphenidine

Diphenidine is a synthetic dissociative belonging to the diarylethylamine family. It was developed in the 1920s as part of research into local anaesthetics, but was not adopted for medical use. Diphenidine later appeared on the new psychoactive substance market as a ketamine-like drug. It acts as an NMDA receptor antagonist and has been associated with severe intoxications, including seizures, psychosis and deaths.

History and chemistry

Diphenidine was first described in patent literature in 1924 during research into local anaesthetic compounds. Its structure contains two phenyl rings attached to an ethylamine chain, with a piperidine ring incorporated into the nitrogen-containing portion. Unlike ketamine and PCP, it does not contain a cyclohexanone ring and is therefore not an arylcyclohexylamine.

The compound reappeared on the recreational market in the early 2010s, particularly after controls were introduced for methoxetamine and other dissociatives. It was sold as a research chemical and promoted as a legal alternative to ketamine.

Pharmacology

Diphenidine acts as an NMDA receptor antagonist. Its activity has been confirmed in vitro using rat hippocampal slices, where its effects were reported to be similar to those of ketamine. NMDA receptor blockade disrupts excitatory glutamate signalling and can produce dissociation, analgesia and changes in consciousness (ACMD review of diphenidine, 2023).

Research has also investigated its effects on other receptor systems, but NMDA antagonism remains the best-established mechanism. The full relationship between receptor activity and the compound’s behavioural effects is not completely understood.

Subjective effects

The PsychonautWiki profile of diphenidine includes widely varying accounts of dissociation, stimulation, euphoria and sensory changes. More intense experiences may involve substantial confusion and detachment from the surroundings.

Physical effects

Reported effects include analgesia, dizziness, nausea, impaired coordination and changes in bodily perception. Some users describe physical euphoria or a feeling of lightness, while others experience motor impairment and difficulty maintaining balance.

Cognitive and perceptual effects

Reports include dissociation, changes in time perception, memory disruption and altered thought organisation. Euphoria and disinhibition may occur, but confusion, agitation, delusions and hallucinations are also described. More intense intoxication can involve a marked reduction in awareness of the environment.

Clinical toxicity

The UK Advisory Council on the Misuse of Drugs reviewed diphenidine after reports of severe intoxication and deaths. Clinical cases included agitation, abnormal behaviour, seizures, unconsciousness and cardiovascular complications. Some cases involved other substances, although diphenidine was considered a significant contributor in several reports.

A 2025 systematic review and UK case series examined deaths involving diarylethylamines, including diphenidine. The authors found that fatal cases were often accidental and frequently involved additional substances, but also identified deaths in which diphenidine or methoxphenidine was the principal drug detected (Corkery and colleagues, 2025).

Toxicity and research limitations

There is no established human toxic range for diphenidine. Clinical reports show that severe intoxication can occur, but the presence of other drugs and limited analytical data complicate interpretation. The long-term effects of repeated exposure and the potential for dependence have not been characterised in controlled studies.

Its dissociative action is established more clearly than its broader toxicological profile. Findings from ketamine or PCP should not be transferred directly to diphenidine, since the compounds belong to different structural families.

Related compounds

Diphenidine is related to Methoxphenidine (MXP) and Ephenidine. These compounds belong to the diarylethylamine group and share NMDA receptor antagonist activity, but differ in their chemical substitutions and reported effects.